Background: Studies suggest that cervical cancer screening practice in the United States is inefficient. The cost and health implications of nonadherence in the screening process com-pared with recommended guidelines are uncertain. Objective: To estimate the benefits, costs, and cost-effec-tiveness of current cervical cancer screening practice and assess the value of screening improvements. Design: Model-based cost-effectiveness analysis
AbstractObjectivesOur aim was to compare the cost-effectiveness of two national cervical cancer scre...
World Health Organization guidelines recommend that cervical cancer screening programs should priori...
ABSTRACTObjectivesThe aim of this study is to assess the cost-effectiveness of 21 alternative cervic...
ImportanceMany cervical cancer screening strategies are now recommended in the United States, but th...
Objective: To estimate the cost-effectiveness of altering the currently recommended interval and age...
Quality adjusted life years are used in cost-effectiveness analyses (CEAs). To calculate QALYs, a 'u...
• Objective: To analyze the costs and benefits of alternate cervical cancer screening schedules amon...
Abstract Cervical cancer screening reduces morbidity and mortality due to cervical cancer. However, ...
textabstractBACKGROUND: Recommended screening policies for cervical cancer differ widely amon...
Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...
Background: 2017 US Preventive Services Task Force guidelines for screening cervical cancer and pre-...
textabstractThe objective of this thesis is to evaluate cervical eaueer screening by assessing its v...
Importance: Evidence on the relative benefits and harms of primary high-risk human papillomavirus (h...
cancer differ widely among countries with respect to tar-geted age range, screening interval, and to...
Because cost-effectiveness of different cervical cytology screening strategies with and without huma...
AbstractObjectivesOur aim was to compare the cost-effectiveness of two national cervical cancer scre...
World Health Organization guidelines recommend that cervical cancer screening programs should priori...
ABSTRACTObjectivesThe aim of this study is to assess the cost-effectiveness of 21 alternative cervic...
ImportanceMany cervical cancer screening strategies are now recommended in the United States, but th...
Objective: To estimate the cost-effectiveness of altering the currently recommended interval and age...
Quality adjusted life years are used in cost-effectiveness analyses (CEAs). To calculate QALYs, a 'u...
• Objective: To analyze the costs and benefits of alternate cervical cancer screening schedules amon...
Abstract Cervical cancer screening reduces morbidity and mortality due to cervical cancer. However, ...
textabstractBACKGROUND: Recommended screening policies for cervical cancer differ widely amon...
Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...
Background: 2017 US Preventive Services Task Force guidelines for screening cervical cancer and pre-...
textabstractThe objective of this thesis is to evaluate cervical eaueer screening by assessing its v...
Importance: Evidence on the relative benefits and harms of primary high-risk human papillomavirus (h...
cancer differ widely among countries with respect to tar-geted age range, screening interval, and to...
Because cost-effectiveness of different cervical cytology screening strategies with and without huma...
AbstractObjectivesOur aim was to compare the cost-effectiveness of two national cervical cancer scre...
World Health Organization guidelines recommend that cervical cancer screening programs should priori...
ABSTRACTObjectivesThe aim of this study is to assess the cost-effectiveness of 21 alternative cervic...